[3-carbamoyl-1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-cyclopropylamino]-2-oxoethyl]indazol-6-yl]methyl formate;2-(3-carbamoyl-6-methoxycarbonylindazol-1-yl)acetic acid;N-[(3-chloro-2-fluorophenyl)methyl]-3-cyclopropylpropanamide;methyl 3-carbamoyl-1-(2-oxopropyl)indazole-6-carboxylate;2,2,2-trifluoroacetaldehyde
C64H63Cl2F5N12O16 — CID 162262930
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-carbamoyl-1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-cyclopropylamino]-2-oxoethyl]indazol-6-yl]methyl formate;2-(3-carbamoyl-6-methoxycarbonylindazol-1-yl)acetic acid;N-[(3-chloro-2-fluorophenyl)methyl]-3-cyclopropylpropanamide;methyl 3-carbamoyl-1-(2-oxopropyl)indazole-6-carboxylate;2,2,2-trifluoroacetaldehyde
[3-carbamoyl-1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-cyclopropylamino]-2-oxoethyl]indazol-6-yl]methyl formate;2-(3-carbamoyl-6-methoxycarbonylindazol-1-yl)acetic acid;N-[(3-chloro-2-fluorophenyl)methyl]-3-cyclopropylpropanamide;methyl 3-carbamoyl-1-(2-oxopropyl)indazole-6-carboxylate;2,2,2-trifluoroacetaldehyde (PubChem CID 162262930) has the molecular formula C64H63Cl2F5N12O16 and a molecular weight of 1422.17 g/mol. Its IUPAC name is [3-carbamoyl-1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-cyclopropylamino]-2-oxoethyl]indazol-6-yl]methyl formate;2-(3-carbamoyl-6-methoxycarbonylindazol-1-yl)acetic acid;N-[(3-chloro-2-fluorophenyl)methyl]-3-cyclopropylpropanamide;methyl 3-carbamoyl-1-(2-oxopropyl)indazole-6-carboxylate;2,2,2-trifluoroacetaldehyde.
Molecular Properties
| Compound Name | [3-carbamoyl-1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-cyclopropylamino]-2-oxoethyl]indazol-6-yl]methyl formate;2-(3-carbamoyl-6-methoxycarbonylindazol-1-yl)acetic acid;N-[(3-chloro-2-fluorophenyl)methyl]-3-cyclopropylpropanamide;methyl 3-carbamoyl-1-(2-oxopropyl)indazole-6-carboxylate;2,2,2-trifluoroacetaldehyde |
|---|---|
| PubChem CID | 162262930 |
| Molecular Formula | C64H63Cl2F5N12O16 |
| Molecular Weight | 1422.17 g/mol |
| Exact Mass | 1420.38 |
| IUPAC Name | [3-carbamoyl-1-[2-[[2-[(3-chloro-2-fluorophenyl)methylamino]-2-oxoethyl]-cyclopropylamino]-2-oxoethyl]indazol-6-yl]methyl formate;2-(3-carbamoyl-6-methoxycarbonylindazol-1-yl)acetic acid;N-[(3-chloro-2-fluorophenyl)methyl]-3-cyclopropylpropanamide;methyl 3-carbamoyl-1-(2-oxopropyl)indazole-6-carboxylate;2,2,2-trifluoroacetaldehyde |
| SMILES | COC(=O)c1ccc2c(C(N)=O)nn(CC(=O)O)c2c1.COC(=O)c1ccc2c(C(N)=O)nn(CC(C)=O)c2c1.NC(=O)c1nn(CC(=O)N(CC(=O)NCc2cccc(Cl)c2F)C2CC2)c2cc(COC=O)ccc12.O=C(CCC1CC1)NCc1cccc(Cl)c1F.O=CC(F)(F)F |
| InChI | InChI=1S/C24H23ClFN5O5.C13H15ClFNO.C13H13N3O4.C12H11N3O5.C2HF3O/c25-18-3-1-2-15(22(18)26)9-28-20(33)10-30(16-5-6-16)21(34)11-31-19-8-14(12-36-13-32)4-7-17(19)23(29-31)24(27)35;14-11-3-1-2-10(13(11)15)8-16-12(17)7-6-9-4-5-9;1-7(17)6-16-10-5-8(13(19)20-2)3-4-9(10)11(15-16)12(14)18;1-20-12(19)6-2-3-7-8(4-6)15(5-9(16)17)14-10(7)11(13)18;3-2(4,5)1-6/h1-4,7-8,13,16H,5-6,9-12H2,(H2,27,35)(H,28,33);1-3,9H,4-8H2,(H,16,17);3-5H,6H2,1-2H3,(H2,14,18);2-4H,5H2,1H3,(H2,13,18)(H,16,17);1H |
| InChIKey | ZZMPKUKDGQYFFP-UHFFFAOYSA-N |
| XLogP | 6.46 |
| TPSA | 411.58 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 99 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1422.17 |
| LogP ≤ 5 | 6.46 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 21 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162262930 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.